ResearcherWan Fang HospitalActive in the last 2 years
Kai‐Cheng Hsu
Matched on ORCID iD 0000-0002-9022-6673; OpenAlex author ID A5057602145. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells. Co-author DOI 10.1080/14756366.2026.2743434↗
- Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening. Last author DOI 10.1002/advs.202416323↗
- Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer. First author DOI 10.1080/14756366.2025.2538673↗
- Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ijbiomac.2024.137296↗
- In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Co-author DOI 10.1080/14756366.2023.2166039↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiow‐Lin Pan · 4 shared papers, 2023–2025 · strength 0.88
- Paper Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer. DOI 10.1080/14756366.2025.2538673↗
- Paper Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer … DOI 10.1002/advs.202416323↗
- Paper Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma. DOI 10.1016/j.ijbiomac.2024.137296↗
- Min‐Wu Chao · 2 shared papers, 2023–2025 · strength 0.47
- Chun-Lin Yang · 2 shared papers, 2025–2026 · strength 0.47
- Paper Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer ce… DOI 10.1080/14756366.2026.2743434↗
- Paper Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer … DOI 10.1002/advs.202416323↗
- Yi-Wen Wu · 2 shared papers, 2025–2026 · strength 0.47
- Paper Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer ce… DOI 10.1080/14756366.2026.2743434↗
- Paper Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer … DOI 10.1002/advs.202416323↗
- Chi-Hsiu Chung · 1 shared paper, 2025 · strength 0.30
- Shiow-Lin Pan · 1 shared paper, 2026 · strength 0.25
- Wan-Hsi Shih · 1 shared paper, 2024 · strength 0.20
- Chao-Di Chang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.